top-genomics-solution-companies - genomics Companies

Pharma Tech Outlook: Pharma Tech Magazine

Avance Biosciences: Leading the Way in GLP/GMP-Compliant Assay Development

Top 10 Genomics Solution Companies – 2020


Since sequencing the human genome for the first time three decades back, genomics has advanced very swiftly over the years. The widespread availability of DNA sequencing data has provided genomics research with an unprecedented level of capability to provide insights. Researchers and practitioners are extensively leveraging it today to deliver accurate diagnoses for elusive cases and unmet clinical needs. Moreover, the advancements in genomics technologies are providing immeasurable value to the whole healthcare system and are altering the way scientists and clinicians understand diseases.

While incorporating genetic data into disease research is not a novel concept, developments in automated sample processing, sequencing, and data analysis are now accelerating new insights into the casual drivers of numerous diseases. Similarly, cohort sourcing, next-generation sequencing, and advanced genomic data analysis can power genomics solutions to enhance decision making during drug discovery and development by providing rich data and new biological insights.

Notably, the use of transmission cryogenic electron microscopy (cryoEM) to decipher macromolecule structures, the improvement of RNA analysis with aptamers, and the advancements in single-cell storage and genomic profiling, are some of the ongoing trends that will make a significant impact in the coming years. Likewise, new synthetic biology approaches are also being developed that could fold and probe the genome across a range of length and time scales.

At this juncture, there is a variety of genomics solution providers available in the market that cater to the different needs of the pharma and biotech companies. To help them choose the solution that best fits their requirement, Pharma Tech Outlook has compiled a list of the top 10 genomics solution providers. The enlisted solution providers are the frontrunners in the market that provide a wide span of features. Besides, the magazine also comprises insights from thought leaders in the sector on the industry trends, best practices, recent innovations, and their advice for the aspiring CIOs.

We present to you Pharma Tech Outlook’s, “Top 10 Genomics Solution Providers – 2020.”

    Top Genomics Solution Companies

  • The Avance Biosciences is a trusted CRO that delivers GLP/GMP-compliant assay development, validation, and sample testing services to support biological drug development. The company is committed to strict adherence to CGMP and GLP regulations enacted by the US, European, Japanese, and other international regulatory agencies. Avance Biosciences’ GLP/GMP compliant genomic and microbial assays make use of the advanced technologies including real-time PCR, ddPCR, Sanger sequencing, next-gen sequencing, Southern blot, and more

  • Breakthrough Genomics is a pioneer in interpreting Whole Exome, Whole Genome, and Gene Panel Tests. Its AI/ML powered software platform ENLITER™ is the only Clinical Interpretation Solution designed to mimic the workflow of a U.S. Board-Certified Medical Geneticist. Collectively, the company’s founders have over 60 years of experience directing genomics programs for leading institutions including Illumina, UCLA, and Quest Diagnostics

  • Illumina specializes in applying innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for the company to deliver innovative, flexible, and scalable solutions to meet the needs of its customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, Illumina strives to meet this challenge. Its innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics

  • BGI Genomics

    BGI Genomics

    BGI Genomics is the world’s leading provider of genomic sequencing services and proteomic services, now serving customers in more than 66 countries. The company provides academic institutions, pharmaceutical companies, health care providers and other organizations with integrated genomic sequencing and proteomic services and solutions across a broad range of applications spanning. The company has almost 20 years of genomics experience helping its customers achieve their research goals by delivering rapid, high quality results using a broad array of cost-effective, cutting-edge technologies, including its own innovative DNBseq™ sequencing technology

  • Congenica


    Congencia is a digital health company enabling genomic medicine with the world leading Clinical Decision Support platform for research use for the rapid analysis and interpretation of genomic data. Built on a foundation of clinical expertise, the company is driven to empower healthcare professionals worldwide to transform health and wellness, improving lives by converting genomic data into actionable information. Its platform can analyze the entire human genome, to not only find the problem but go further, collect a wealth of information, trillions of data points, then interpret and understand every detail

  • Freenome


    Freenome is radically transforming the way patients with cancer are managed, equipping people everywhere with the knowledge and tools they need to maintain a healthier life, and one day, prevent cancer altogether. Since our beginning in 2014, Freenome has had a clear vision— building a multi-disciplinary team with expertise in computational biology and machine learning techniques to reinvent disease management through early detection and precision intervention

  • Macrogen


    Macrogen, a leading company in precision medicine and biotechnology, was established on June 5, 1997 based on the Genomic Medicine Institute of the Seoul National University College of Medicine. In February 2000, Macrogen became the first ever bio venture in Korea to be listed on the KOSDAQ. Since then, Macrogen has continued to be actively engaged in R&D fields of genetic and genomic analyses. Today, Macrogen has become a global expert in genomic analysis and a leader in Korean biotechnology, working closely with over 18,000 research clients across 153 countries worldwide. In addition to providing services to clients all over the world, Macrogen contributes to the advancement of bioindustries through a wide range of R&D and CSR activities

  • Pacific Biosciences

    Pacific Biosciences

    Based in the heart of Silicon Valley, Pacific Biosciences (PacBio) provides sophisticated genomic analysis systems that deliver invaluable insights for scientists who strive to resolve complex genetic challenges. PacBio sequencing offers the most comprehensive view of genomes, transcriptomes, and epigenomes — including the full spectrum of genetic variation — by providing the longest average read lengths, highest consensus accuracy, and most uniform coverage of any sequencing technology on the market today. Ideal for de novo genome assembly and genetic variation characterization of humans, animals, plants, and microbes, this system features high-performance optics, automated liquid handling, and an intuitive, intelligent operating system

  • Q2 Solutions

    Q2 Solutions

    Q2 Solutions is a leading clinical trial laboratory services organization with bioanalytical, genomics, vaccines, flow cytometry, anatomic pathology, immunoassay, companion diagnostics and central laboratory services with secure, enterprise-wide biospecimen and consent management solutions. A joint venture of IQVIA (formerly QuintilesIMS) and Quest Diagnostics, Q2 Solutions combines the best of each parent organization’s clinical trials laboratory services capabilities to help its customers develop drugs faster and more efficiently



    QIAGEN is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics)